| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | February 27, 2024 4:30 P.M. |
| Form: | S-1 | ||||||
| |||||||
Save time and jump to the most important pieces.
8-K - Lucy Scientific Discovery, Inc. (0001865127) (Filer)
8-K - Lucy Scientific Discovery, Inc. (0001865127) (Filer)
NT 10-Q - Lucy Scientific Discovery, Inc. (0001865127) (Filer)
Lucy Scientific Discovery Inc. (NASDAQ:LSDI), a Company dedicated to advancing the understanding and applications of psychotropic medicines, improving mental health outcomes, and enhancing well-being for individuals worldwide, announces that it has a hearing scheduled for June 25, 2024 before a Nasdaq Hearings Panel (the "Panel") regarding its plan to regain compliance with Nasdaq Listing Rule 5550(b) (the "Stockholders' Equity Rule"). On May 21, 2024, the Company received a letter from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq") that, per Nasdaq Listing Rule 5250(c)(1) (the "Filings Rule"), the Company is delinquent in filing its Quarterly Report on Form 1
Lucy Scientific Discovery Inc. (NASDAQ:LSDI), a Company dedicated to advancing the understanding and applications of psychotropic medicines, improving mental health outcomes, and enhancing well-being for individuals worldwide announces that the Company will effect a one-for-ten (1-10) reverse split of its common shares. The Company is effecting the reverse split in an effort to regain compliance with the $1.00 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). The reverse share split will become effective on Monday, February 26, 2024 (the "Effective Date"), and the shares are expected to begin trading on the split-adjusted b
DENVER, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Lucy Scientific Discovery Inc. (NASDAQ:LSDI) is a pioneer in alternative mental health treatments and looking to grab its share of the leadership mantle, as it uncovers alternative mental health treatments. From herbal remedies to psychedelics, like psilocybin and MDMA, Lucy Scientific is working to provide the ingredients for groundbreaking mental health therapies and are well positioned to support this space as it continues to grow. Mental Health Refocus Mental health issues and treatments are nearly as old as mankind, but, as mental health disorders reach epidemic proportions, affecting millions of Americans every year, it seems that the tre
VANCOUVER, BC / ACCESSWIRE / September 12, 2023 / Lucy Scientific Discovery Inc. (NASDAQ:LSDI), a publicly traded company focused on the development, sale, delivery, and manufacturing of psychotropic products, recently announced its acquisition of all High Times IP and brand assets - has just announced the acquisition of BlueSky Wellness Inc., along with the full BlueSky portfolio of brands adding psychotropic products to its catalog, expanding its footprint into the global wellness market. The BlueSky Wellness family of wellness focused ecommerce brands includes Keoni, Keoni Sport, Blush Wellness and AMMA Healing, which have generated over $20 million in revenue in each of the last two y
VANCOUVER, British Columbia, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Lucy Scientific Discovery Inc. ("Lucy" or "the Company") (NASDAQ:LSDI), a leading psychotropic innovator announces the acquisition of the intellectual property (IP) of High Times, the most recognizable and iconic brand in the cannabis industry. This acquisition provides a stream of high-margin licensing and royalty income from the well-regarded High Times, Cannabis Cup, and 420.com brands, including their respective domain names. Lucy will issue 19.9% of its outstanding stock to High Times and make payments semi-annually for the next 5 years based on EBITDA generated from the acquired IP, which can be settled with either s
4 - Lucy Scientific Discovery, Inc. (0001865127) (Issuer)
4 - Lucy Scientific Discovery, Inc. (0001865127) (Issuer)
4 - Lucy Scientific Discovery, Inc. (0001865127) (Issuer)
VANCOUVER, British Columbia, July 13, 2023 (GLOBE NEWSWIRE) -- Lucy Scientific Discovery Inc. (NASDAQ:LSDI), a leader and innovator in the psychotropic industry, announced the appointment of current Executive Chairman Richard Nanula as the new Chief Executive Officer, effective immediately. Nanula will retain his Chairman role while succeeding Chris McElvany as Chief Executive Officer, who will transition into a consulting role with the Company. Nanula brings to Lucy decades of senior leadership experience from several of the largest companies in the world having been a Senior Executive at The Walt Disney Company, Amgen, Colony Capital and Starwood Hotels and Resorts. Over the course of h
VANCOUVER, British Columbia, March 29, 2023 (GLOBE NEWSWIRE) -- Lucy Scientific Discovery Inc. ("Lucy" or "The Company") (NASDAQ:LSDI), an early-stage psychedelics manufacturing company, announced today that former British Columbia Solicitor General Kash Heed has joined the company as a Special Advisor. Among other important contributions, Mr. Heed will apply his knowledge from decades of public service to help the company successfully navigate Canada's rapidly evolving drug policy landscape and growing budget focused on mental health and safe-supply programs. Mr. Heed started his public service 44 years ago with the Vancouver Police Department (VPD). With the VPD, he pioneered initia